China’s First 2024 Biotech Acquisition by DCTY
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
- Latest
- Trending
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
Research from The University of British Columbia shows that long QT syndrome can be diagnosed using AI and ECG data, ...
A Louisiana woman files lawsuit against Amazon and pharmaceutical companies over contaminated eye drops leading to severe injuries. Consumer trust ...
New findings challenge traditional beliefs about cultural transitions between modern humans and Neanderthals during the Upper Paleolithic period.
The rise of rental e-bikes is shaking up the transport industry in the UK, with HumanForest leading the way by ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.